Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Birgit C P Koch

Showing results (131-140 of 205) with videos related to

Pageof 21
Sort By:
Antibiotics (Basel, Switzerland)|February 25, 2023
Meropenem Model-Informed Precision Dosing in the Treatment of Critically Ill Patients: Can We Use It?Letao Li, Sebastiaan D T Sassen, Tim M J Ewoldt, et al.
Blood Purification|November 5, 2023
The Clearance of Midazolam and Metabolites during Continuous Renal Replacement Therapy in Critically Ill Patients with COVID-19Tim J L Smeets, Hilde R H de Geus, Abraham J Valkenburg, et al.
Transplantation Direct|April 1, 2017
Overweight Kidney Transplant Recipients Are at Risk of Being Overdosed Following Standard Bodyweight-Based Tacrolimus Starting DoseLouise M Andrews, Brenda C M de Winter, Jiang-Tao Tang, et al.
Bipolar Disorders|June 17, 2026
Lithium Dispensing Patterns in Dutch Youth: Prevalence, Incidence Dosages, and Duration of Use From 2011 to 2022Ravish N Gangapersad, Lisa T Ringeling, Jens H J Bos, et al.
Clinical Pharmacokinetics|April 10, 2022
Hyperinflammation Reduces Midazolam Metabolism in Critically Ill Adults with COVID-19Tim J L Smeets, Abraham J Valkenburg, Mathieu van der Jagt, et al.
Expert Opinion on Drug Safety|May 19, 2020
Psychotropic drug concentrations and clinical outcomes in children and adolescents: a systematic reviewSanne M Kloosterboer, Denise Vierhout, Jana Stojanova, et al.
Clinical Pharmacokinetics|January 21, 2020
Population Pharmacokinetics of Imipenem in Critically Ill Patients: A Parametric and Nonparametric Model Converge on CKD-EPI Estimated Glomerular Filtration Rate as an Impactful CovariateFemke de Velde, Brenda C M de Winter, Michael N Neely, et al.
British Journal of Clinical Pharmacology|September 30, 2017
Population pharmacodynamic modelling of midazolam induced sedation in terminally ill adult patientsLinda G Franken, Brenda C M de Winter, Anniek D Masman, et al.
Dermatology (Basel, Switzerland)|September 1, 2016
Combination Therapy of Etanercept and Fumarates versus Etanercept Monotherapy in Psoriasis: A Randomized Exploratory StudyJi Sun van Bezooijen, Deepak M W Balak, Martijn B A van Doorn, et al.
JCO Oncology Practice|June 7, 2024
Effect of Switching the Histamine-1 Receptor Antagonist Clemastine to Cetirizine in Paclitaxel Premedication Regimens: The H1-Switch StudyRuben Malmberg, Leni van Doorn, Juul M Cox, et al.
Pageof 21

Showing results (131-140 of 205) with videos related to

Sort By:
Pageof 21
Antibiotics (Basel, Switzerland)|February 25, 2023
Meropenem Model-Informed Precision Dosing in the Treatment of Critically Ill Patients: Can We Use It?Letao Li, Sebastiaan D T Sassen, Tim M J Ewoldt, et al.
Blood Purification|November 5, 2023
The Clearance of Midazolam and Metabolites during Continuous Renal Replacement Therapy in Critically Ill Patients with COVID-19Tim J L Smeets, Hilde R H de Geus, Abraham J Valkenburg, et al.
Transplantation Direct|April 1, 2017
Overweight Kidney Transplant Recipients Are at Risk of Being Overdosed Following Standard Bodyweight-Based Tacrolimus Starting DoseLouise M Andrews, Brenda C M de Winter, Jiang-Tao Tang, et al.
Bipolar Disorders|June 17, 2026
Lithium Dispensing Patterns in Dutch Youth: Prevalence, Incidence Dosages, and Duration of Use From 2011 to 2022Ravish N Gangapersad, Lisa T Ringeling, Jens H J Bos, et al.
Clinical Pharmacokinetics|April 10, 2022
Hyperinflammation Reduces Midazolam Metabolism in Critically Ill Adults with COVID-19Tim J L Smeets, Abraham J Valkenburg, Mathieu van der Jagt, et al.
Expert Opinion on Drug Safety|May 19, 2020
Psychotropic drug concentrations and clinical outcomes in children and adolescents: a systematic reviewSanne M Kloosterboer, Denise Vierhout, Jana Stojanova, et al.
Clinical Pharmacokinetics|January 21, 2020
Population Pharmacokinetics of Imipenem in Critically Ill Patients: A Parametric and Nonparametric Model Converge on CKD-EPI Estimated Glomerular Filtration Rate as an Impactful CovariateFemke de Velde, Brenda C M de Winter, Michael N Neely, et al.
British Journal of Clinical Pharmacology|September 30, 2017
Population pharmacodynamic modelling of midazolam induced sedation in terminally ill adult patientsLinda G Franken, Brenda C M de Winter, Anniek D Masman, et al.
Dermatology (Basel, Switzerland)|September 1, 2016
Combination Therapy of Etanercept and Fumarates versus Etanercept Monotherapy in Psoriasis: A Randomized Exploratory StudyJi Sun van Bezooijen, Deepak M W Balak, Martijn B A van Doorn, et al.
JCO Oncology Practice|June 7, 2024
Effect of Switching the Histamine-1 Receptor Antagonist Clemastine to Cetirizine in Paclitaxel Premedication Regimens: The H1-Switch StudyRuben Malmberg, Leni van Doorn, Juul M Cox, et al.
Pageof 21